Match tier
Likely match
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
G
Glenn D. Newport
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
High Impact
Researcher
Also affiliated: American Institute of Certified Public Accountants (2016); United States Food and Drug Administration (2002–2016); Center for Drug Evaluation and Research (2016); Naval Air Warfare Center Weapons Division (1987); Naval Health Research Center (1988); Zimmer Biomet (United States) (2003); Food and Drug Administration (1981)
Faculty Researcher
31 h-index
86 pubs
4,256 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Glenn D. Newport is a researcher with a focus on the neurotoxicological effects of various substances, particularly in animal models. His work has investigated the impact of methamphetamine on dopamine pathways in the brain, utilizing rat and mouse models. Newport's research has also explored the neurotoxic properties of peptides and other compounds, examining their effects on brain regions like the hippocampus. He has a publication record of 86 papers, with over 4,240 citations, and an h-index of 31. Newport has collaborated with researchers at the National Center for Toxicological Research, including Qiangen Wu and Syed F. Ali, on multiple shared publications. His recent publications include retraction notices for work on Aβ25–35 peptide and quinolinic acid.
Metrics
- h-index: 31
- Publications: 86
- Citations: 4,256
Selected Publications
-
Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296] (2025)
-
Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78] (2024)
-
MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates (2016)
-
In Vivo Monitoring of Sevoflurane-induced Adverse Effects in Neonatal Nonhuman Primates Using Small-animal Positron Emission Tomography (2016)
-
Positron Emission Tomography with [18F]FLT Revealed Sevoflurane-Induced Inhibition of Neural Progenitor Cell Expansion in vivo (2014)
-
Developmental toxicity assay using high content screening of zebrafish embryos (2014)
-
Effects of Copper Nanoparticles on Rat Cerebral Microvessel Endothelial Cells (2012)
-
MicroPET/CT Imaging of [ <sup>18</sup> F]-FEPPA in the Nonhuman Primate: A Potential Biomarker of Pathogenic Processes Associated with Anesthetic-Induced Neurotoxicity (2012)
-
L-carnitine attenuates anesthetic-induced increases in a marker of glial activation in the developing monkey brain (2012)
-
Minimally invasive quantitative assessment of inhalation anesthetic-induced brain cell death using microPET imaging (2011)
-
RETRACTED: On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression (2011)
-
Silver Nanoparticle Induced Blood-Brain Barrier Inflammation and Increased Permeability in Primary Rat Brain Microvessel Endothelial Cells (2010)
-
Brain microvessel endothelial cells responses to gold nanoparticles:<i>In vitro</i>pro-inflammatory mediators and permeability (2010)
-
RETRACTED: On the early toxic effect of quinolinic acid: Involvement of RAGE (2010)
-
MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH (2010)
Collaboration Network
Top Collaborators
Elvis Cuevas
2 shared publications
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Susan M. Lantz
National Center for Toxicological Research
2 shared publications
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Qiangen Wu
National Center for Toxicological Research
2 shared publications
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Julio C. Tobón-Velasco
Instituto Nacional de Neurología y Neurocirugía (MX)
2 shared publications
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Syed F. Ali
National Center for Toxicological Research
2 shared publications
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Abel Santamarı́a
2 shared publications
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Becky Divine
National Center for Toxicological Research
1 shared publication
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
Merle G. Paule
National Center for Toxicological Research
1 shared publication
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
Ashraf Virmani
Sigma Tau (Italy) (IT)
1 shared publication
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Similar Researchers
Based on overlapping research topics
Lauren R. Fitzgerald
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
John P. Culver
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
John T. Striednig
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Jai Shankar K. Yadlapalli
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal Behavior and Welfare Studies
Mary E Shepard
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Justin R. Nickell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes